Al Altomari
Chief Executive Officer, Barrier Therapeutics, Inc.

Edwin A. Bescherer, Jr
Retired Chief Financial Officer, Dun & Bradstreet Corporation

Rolf Classon, Auxilium, Chairman of the Board
Chairman of the Board of Hillenbrand Industries Inc., Former Chairman of the Executive Committee of Bayer HealthCare AG

Philippe O. Chambon, MD, PhD
Managing Director of New Leaf Venture Partners, LLC

Oliver Fetzer, PhD
Senior Vice President, Corporate Development and Research and Development, Cubist Pharmaceuticals

Armando Anido
Chief Executive Officer and President

Dennis J. Purcell
Senior Managing Partner of Aisling Capital LLC